QuidelOrtho (QDEL) Research & Development (2021 - 2024)

QuidelOrtho (QDEL) has 4 years of Research & Development data on file, last reported at $59.2 million in Q1 2024.

• For the quarter ending Q1 2024, Research & Development fell 4.98% year-over-year to $59.2 million; the trailing twelve-month figure through Mar 2024 stood at $303.2 million (up 8.13% YoY), and the FY2024 full-year result was $218.7 million, down 10.73% from the prior year.
• Research & Development retreated to $59.2 million in Q1 2024, from $118.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $118.8 million in Q4 2023 to a low of $22.6 million in Q3 2021.
• A 4-year average of $59.7 million and a median of $62.3 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 176.79% in 2022 and decreased 4.98% in 2024, its largest moves.
• Tracing QDEL's Research & Development over 4 years: stood at $23.7 million in 2021, then jumped by 176.79% to $65.6 million in 2022, then soared by 81.1% to $118.8 million in 2023, then slumped by 50.17% to $59.2 million in 2024.
• Business Quant data shows QDEL's Research & Development at $59.2 million in Q1 2024, $118.8 million in Q4 2023, and $62.4 million in Q4 2023.